Related Experiment Video

Updated: Jun 29, 2026

Taking the Next Step: a Neural Coaptation Orthotopic Hind Limb Transplant Model to Maximize Functional Recovery in Rat
14:18

Taking the Next Step: a Neural Coaptation Orthotopic Hind Limb Transplant Model to Maximize Functional Recovery in Rat

Published on: August 30, 2020

Conclusion and future directions

Wolfram E Samlowski1, Nicholas J Vogelzang

  • 1Section of Melanoma, Renal Cancer and Immunotherapy, Nevada Cancer Institute, Las Vegas, NV 89135, USA. wsamlowski@nvcancer.org

Cancer Journal (Sudbury, Mass.)
|October 7, 2008
PubMed

Insights

Recent advances in understanding kidney cancer molecular biology have revolutionized metastatic renal cancer treatment. New therapies offer significant improvements in progression-free and overall survival for patients with this disease.

Area of Science:

  • Oncology
  • Nephrology
  • Molecular Biology

Background:

  • Metastatic renal cancer treatment was historically ineffective.
  • Cytokine therapies like interferon-alpha and interleukin-2 showed limited response rates and significant toxicity.
  • Recent molecular discoveries have transformed kidney cancer management.

Purpose of the Study:

  • To review clinical progress in metastatic renal cancer treatment.
  • To highlight current needs and future directions in the field.
  • To discuss recent breakthroughs driven by molecular understanding.

Main Methods:

  • Review of clinical progress and breakthroughs in metastatic renal cancer treatment.
  • Analysis of the impact of molecular-level understanding on therapeutic strategies.
  • Discussion of cytokine-based therapies and their limitations.

Main Results:

  • Substantial gains in progression-free survival have been achieved.
  • Significant improvements in overall survival are now evident.
  • New therapeutic approaches have emerged from molecular insights.

Conclusions:

  • The molecular understanding of kidney cancer has led to major therapeutic breakthroughs.
  • Current treatments offer improved outcomes for metastatic renal cancer patients.
  • The field is rapidly evolving with promising future directions.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
The Scientific Method03:50

The Scientific Method

Chemistry is an empirical science. Scientists often pose questions to understand the chemistry in everyday life and seek answers to these questions. To achieve this, scientists follow a definitive series of steps that together make up the Scientific Method. This approach involves making observations, asking questions, building a hypothesis, conducting experiments, analyzing results, and forming a conclusion.
Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null hypothesis and 'fail to...